IDXX IDEXX LABORATORIES INC /DE
P/E
40.07
Forward P/E
33.78
Price/Sales
9.88
Beta
1.548
Div Yield
--
Market Cap
--
Company Analysis
Latest News
IDEXX Laboratories beats first quarter 2026 estimates with 11% organic growth in CAG diagnostics and raises full-year guidance.
IDEXX Laboratories reported first quarter 2026 revenue of $1.141 billion, up 14% as reported and 11% on an organic basis, beating estimates. Earnings per share...
IDEXX Laboratories Inc Q1 2026 Earnings Preview: What Analysts Expect on May 05, 2026
IDEXX Laboratories is expected to report Q1 2026 revenue of $1.12 billion and earnings per share of $3.42, with the stock currently trading at $567.46 against...